Literature DB >> 3657391

Plasma cholecystokinin-octapeptide like immunoreactivity in patients with hepatic cirrhosis.

S Kanayama1, S Himeno, Y Higashimoto, Y Yamasaki, T Kitani, S Tarui.   

Abstract

Molecular forms of cholecystokinin (CCK) in the peripheral circulation were studied in normal subjects and cirrhotic patients. Fractionation of plasma extract collected 20 min after intraduodenal infusion of fat revealed four major peaks by Sephadex G-50 column chromatography in normal subjects. Peak I eluted at a position similar to CCK-33, peaks II and III eluted between CCK-33 and CCK-14, and peak IV eluted between CCK-14 and CCK-8. In cirrhotic patients, there was a prominent peak (peak V) eluted at a position similar to CCK-8, in addition to those four peaks. These findings are consistent with the previous observations of hepatic elimination of CCK-8, and suggest that smaller forms of CCK similar in size to CCK-8 are not major forms of CCK in plasma in normal subjects but circulate substantially in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3657391     DOI: 10.1016/0024-3205(87)90743-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Reduced Bisulfite Sequencing: Quantitative Base-Resolution Sequencing of 5-Formylcytosine.

Authors:  Michael J Booth; Shankar Balasubramanian
Journal:  Methods Mol Biol       Date:  2021

2.  Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats.

Authors:  I Tachibana; N Watanabe; H Shirohara; T Akiyama; S Nanano; M Otsuki
Journal:  Int J Pancreatol       Date:  1995-04

3.  Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.

Authors:  H Shirohara; A Tabaru; M Otsuki
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

4.  Cholecystokinin is not a physiological regulator of gastric pepsin secretion in rats.

Authors:  S Kawabata; S Kanayama; Y Shinomura; S Kondo; Y Matsuzawa
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

5.  Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis.

Authors:  M Pompili; G L Rapaccini; E Caturelli; D Curró; P Montuschi; M D'Amato; A Aliotta; A Grattagliano; A Cedrone; M Anti
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Pancreatic trophism in experimental liver cirrhosis.

Authors:  I Nagy; F Hajnal; G Mohácsi; J Németh; Z Lászik; A Pap
Journal:  Int J Pancreatol       Date:  1993-10

7.  Nutritional care in hospitalized patients with chronic liver disease.

Authors:  Dep K Huynh; Shane P Selvanderan; Hugh A J Harley; Richard H Holloway; Nam Q Nguyen
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

8.  Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

Authors:  R A Liddle; B J Gertz; S Kanayama; L Beccaria; L D Coker; T A Turnbull; E T Morita
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.